• Who We Are
• Contact Us

2^nd Annual

Market Access

Canada Summit

October 4^th - 5^th, Hyatt Regency, Toronto

What Other's Are Saying... See More Testimonials

09 Presentations

Here a few presentations from the 2009 summit

• 

  Doug Grant

  Download this Podcast

  Vice President, Bayer

• Strategies you need to implement to get the best probability of national coverage for your drug

  • Establish where the future funding and control will lie: PMPRB or Provincial authority and what this will mean for the price of your drug.
  • Discover strategies which dictate the provincial thinking when discussing your reimbursement.
  • Develop best-practice methods in listing negotiations and how value can lead to success in pricing.

• 

  Krista Scaldwell

  Download this Podcast

  Vice President, BMS

• The Provincial Challenge: Examine real challenges and opportunities when getting your drug approved in the provinces and learn the crucial do's and dont's when in negotiations

  • The methods you need to know when presenting drug safety, costeffectiveness and pricing agreements between each province and what the major barriers are that you will face.
  • Discover what priority the provinces give for approval and what added value you need to show to win them over.
  • Establish a clear plan that ensures you continue to improve on dialogue and relationships to develop a win-win situation in the provinces.

• 

  Brian O'rouke

  Download this Podcast

  Vice President , CDR

• A Policy Update from the Common Drug Review (CDR)

  • An update on the CDR process, timelines and activity you need to know for effective drug approval.
  • New initiatives introduced by the CDR.
  • Understand how you can solidify your submission to the CDR.
  • Future trends in the reimbursement environment you need to be aware of. Brian O'Rourke Vice President, Common Drug Review (CDR)

• 

  Barbara Ouellet

  Download this Podcast

  Executive Director, PMPRB

• The Changing PMPRB landscape and the impact of the new Excessive Pricing Guidelines

  • What are the main changes to the PMPRB's 1994 Excessive Pricing Guidelines?
  • What are the implications of the new Guidelines?
  • What can be expected in the future and what measures should be taken.

Conferences & Trade shows